HUMULIN 30/70 CARTRIDGE 70 UNIT
INSULIN ISOPHANE HUMAN BIOSYNTHETIC : 70 UNIT INSULIN INJECTION HUMAN BIOSYNTHETIC : 30 UNIT · DIN 01959212 · ELI LILLY CANADA INC
Health Canada status: MARKETED
What is HUMULIN 30/70 CARTRIDGE?
HUMULIN 30/70 CARTRIDGE 70 UNIT contains INSULIN ISOPHANE HUMAN BIOSYNTHETIC : 70 UNIT INSULIN INJECTION HUMAN BIOSYNTHETIC : 30 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01959212, held by ELI LILLY CANADA INC, supplied as SUSPENSION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 11-Dec-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is HUMULIN 30/70 CARTRIDGE used for?
HUMULIN (insulin, human biosynthetic) is indicated for the treatment of insulin requiring diabetic patients. HUMULIN-R only should be used for the treatment of emergencies such as diabetic coma and pre-coma and in diabetics undergoing surgery, but not HUMULIN-N, or HUMULIN MIXTURES.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01959212 |
|---|---|
| Brand name | HUMULIN 30/70 CARTRIDGE |
| Generic / active ingredient | INSULIN ISOPHANE HUMAN BIOSYNTHETIC : 70 UNIT INSULIN INJECTION HUMAN BIOSYNTHETIC : 30 UNIT |
| Manufacturer | ELI LILLY CANADA INC |
| Strength | 70 UNIT |
| Dosage form | SUSPENSION |
| Route of administration | SUBCUTANEOUS |
| Schedule | Schedule D |
| ATC code | A10AD01 INSULIN (HUMAN) |
| AHFS class | 68:20.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Dec-1997 |
| Original market date | 1992-12-31 00:00:00 |
How is it stored and handled?
Prior to first use insulin should be stored in a cold place (2 - 8 ℃), preferably in a refrigerator, but not in a freezer. Do not let it freeze or leave it in direct sunlight. Expiration dates are stated on the labels. When in current use, vials, cartridges and prefilled pens should be stored at room temperature and discarded after 28 days.
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code A10AD01 INSULIN (HUMAN). 4 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ENTUZITY KWIKPEN | 500 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02466864 |
| HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) | 30 UNIT | SUSPENSION | ELI LILLY CANADA INC | MARKETED | DIN 00795879 |
| NOVOLIN GE 30/70 | 30 UNIT | SUSPENSION | NOVO NORDISK CANADA INC | MARKETED | DIN 02024217 |
| HUMULIN 10/90 CARTRIDGE | 90 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 01962639 |
| HUMULIN 10/90 INJ | 10 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 00889113 |
| HUMULIN 20/80 CARTRIDGE | 80 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 01962655 |
| HUMULIN 20/80 INJ | 80 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 00889105 |
| HUMULIN 40/60 CARTRIDGE | 40 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 01962647 |
| HUMULIN 40/60 INJ | 40 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 00889091 |
| HUMULIN 50/50 CARTRIDGE | 50 UNIT | SUSPENSION | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 01962663 |
Who else supplies INSULIN (HUMAN) worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. INSULIN (HUMAN) appears in 441 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.